124 related articles for article (PubMed ID: 24001380)
21. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
22. PUVA-cream photochemotherapy for the treatment of localized scleroderma.
Grundmann-Kollmann M; Ochsendorf F; Zollner TM; Spieth K; Sachsenberg-Studer E; Kaufmann R; Podda M
J Am Acad Dermatol; 2000 Oct; 43(4):675-8. PubMed ID: 11004625
[TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
[TBL] [Abstract][Full Text] [Related]
24. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
27. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
Shephard SE; Schregenberger N; Dummer R; Panizzon RG
Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
[TBL] [Abstract][Full Text] [Related]
29. [Cream PUVA photochemotherapy].
Stege H; Berneburg M; Ruzicka T; Krutmann J
Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
[TBL] [Abstract][Full Text] [Related]
30. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema.
Tzaneva S; Kittler H; Thallinger C; Hönigsmann H; Tanew A
Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):101-5. PubMed ID: 19292787
[TBL] [Abstract][Full Text] [Related]
31. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice.
Miyauchi-Hashimoto H; Okamoto H; Sugihara A; Horio T
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):125-30. PubMed ID: 15888128
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of PUVA bath phototoxicity.
Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of 8-methoxypsoralen following PUVA-bath photochemotherapy.
von Kobyletzki G; Hoffmann K; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 1998; 14(3-4):136-8. PubMed ID: 9779504
[TBL] [Abstract][Full Text] [Related]
35. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
37. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
38. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
39. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
[TBL] [Abstract][Full Text] [Related]
40. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
